Giannis Mountzios, Director of 4th Oncology Department and Clinical Trials Unit at Henry Dunant Hospital Center, shared on LinkedIn:
“Just ahead of WCLC26, an exquisite cutting-edge Review in Journal of Thoracic Oncology on ADCs in SCLC by amazing author group Federico Monaca, Musku A., Stephen Liu, Luis P., Raffaele Califano.
A must-read for every SCLC-warrior exemplifying that the combination of TCEs and ADC holds promise for deep and durable responses in ES-SCLC.”
Title: Antibody–Drug Conjugates in SCLC: DLL3, B7-H3, TROP2, and Beyond
Authors: Federico Monaca, Igor Gomez-Randulfe, Javier Torres-Jiménez, Muskan Agarwal, Stephen V. Liu, Luis Paz-Ares, Raffaele Califano
You may also find this interesting:
Exercise in Lung Cancer Care: From Supportive Evidence to Global Implementation With IREX-Lung